Activity of Lurbinectedin in Second-Line Small Cell Lung Cancer Patients Who Are Candidates for Re-Challenge With First-Line Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Antitumor Activity of Lurbinectedin in Second-Line Small Cell Lung Cancer Patients Who Are Candidates for Re-Challenge With the First-Line Treatment
Lung Cancer 2020 Dec 01;150(xx)90-96, V Subbiah, L Paz-Ares, B Besse, V Moreno, S Peters, MA Sala, JA López-Vilariño, C Fernández, C Kahatt, V Alfaro, M Siguero, A Zeaiter, K Zaman, R López, S Ponce, V Boni, J Arrondeau, JP Delord, M Martínez, L Wannesson, A Antón, J Valdivia, A Awada, R Kristeleit, ME Olmedo, MJ Rubio, J Sarantopoulos, SP Chawla, J Mosquera-Martinez, M D' Arcangelo, A Santoro, VM Villalobos, J Sands, J TrigoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.